OptraSCAN, the California-headquartered digital pathology company backed by Molbio Diagnostics, has received USFDA 510(k) clearance for its integrated digital pathology system, marking a major milestone in AI-driven cancer diagnostics and digital pathology innovation.
Tag: Molbio Diagnostics
Molbio & UE LifeSciences Partner to Expand iBreastExam Globally for Early Breast Cancer Detection
Molbio Diagnostics and UE LifeSciences announce an exclusive collaboration to expand iBreastExam, a radiation-free, painless, and FDA-cleared breast health screening device, across India, Africa, the Middle East, and beyond. The partnership aims to bring accessible early detection to millions of women in over 50 countries.
Molbio Diagnostics Files DRHP with SEBI: Plans ₹200 Crore Fresh Issue, Major Expansion Ahead
Goa-based Molbio Diagnostics, backed by Temasek and MOPE, has filed its DRHP with SEBI for an IPO comprising a fresh issue of ₹200 crore and an OFS of 1.25 crore equity shares. The funds will be utilized for R&D infrastructure, manufacturing expansion, and corporate purposes.
Molbio Diagnostics Empowers Philippines to Fast-Track TB Elimination with Truenat and Ultra-Portable X-ray Tech
With over 190,000 undiagnosed TB cases annually, the Philippines is turning to Indian innovation to close the gap. Through Molbio Diagnostics' WHO-endorsed Truenat® systems and portable X-ray solutions, the country is enhancing its ability to screen, diagnose, and treat TB—especially in remote and underserved communities.
Molbio Diagnostics Strengthens CSR Impact with New Therapy Units for Children with Disabilities in Goa
Molbio Diagnostics has expanded its CSR footprint by inaugurating Occupational Therapy and Audiology Units at Aastha’s Centre of Excellence in Goa. These facilities aim to benefit over 100 children with disabilities annually by offering sensory and communication therapies, bridging key healthcare access gaps in the state.